top of page

Selling Pharmaceuticals & Supplements

Pharmaceuticals & Supplements

Pharmaceutical and supplement companies are integral to the healthcare industry. With the increasing focus on health and wellness, businesses in this category are poised for growth, attracting interest from investors and larger corporations.

Frequently Asked Questions

How are Pharmaceutical and Pharmacy Practices are Valued?

There are number of valuation methods that can be used in determining the valuation of your company. The most common is based on the top line revenue, bottom line adjusted EBITDA and a multiplier based on market conditions. To get a free and confidential valuation of your company, fill out the form, and one our managing directors will be able to provide you a current market valuation for your company.

How long will it take for me to sell my pharmaceutical or supplement company to a potential buyer or an investor?

It is generally a 6-9 months process from the time we receive all the information we need from you to go to market.

Who are the typical buyers in the pharmaceutical and supplement market?

Large pharmaceutical companies, private equity firms, and health and wellness companies.

What regulatory considerations should I be aware of when selling my company?

Ensure compliance with FDA regulations and international standards.

What influences the value of a pharmaceutical or supplement company?

Valuation is based on intellectual property, regulatory approvals, and market share.

Active Listings

Holistic Solution to Global Health Challenges in Oral Care and Nutrition – A Collection of Global Patents and IPs

State:

Not Disclosed

Category:

Pharmaceuticals & Supplements

Revenue

-

Asking Price:

-

Listing Code:

XYRX2D

Clinical-Stage Biopharma with a Novel, Targeted Therapy for Brain Tumors

State:

Texas

Category:

Pharmaceuticals & Supplements

Revenue

-

Asking Price:

-

Listing Code:

TXPH1B

Premier Nutritional Supplements Company with Proven Clinical Benefits

State:

Not Disclosed

Category:

Pharmaceuticals & Supplements

Revenue

-

Asking Price:

-

Listing Code:

XYPH1C

Phase I-Ready Biopharmaceutical Asset Targeting High-Growth Markets

State:

Not Disclosed

Category:

Pharmaceuticals & Supplements

Revenue

-

Asking Price:

-

Listing Code:

XYPH1D

Currently, there are no available listings. We are actively seeking new opportunities for our buyers and investors. Please contact us for more information

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About us
 

PRIME exits is a registered trademark for Nazeri & Company LLCan independent affiliate of American Healthcare Capital. Nazeri & Company, Co. Ltd. is an international subsidiary of Nazeri & Company LLC. We are a merger and acquisition advisory firm focused on the healthcare industry with a network of 50+ M&A analysts and advisors. 

 

Locations

Los Angeles

Las Vegas

Bangkok

Vancouver, BC

Milan, Italy

Contact us

 

1-800- 424-3388 HEAD OFFICE

1-310-625-7889 Jack Eskenazi

1-702-506-3392 Dr. Allen Nazeri 

Valuation Team

Jack@ahcteam.com

Allen@ahcteam.com

Allen@pexits.com

PRIME exits M&A Bio Barcode
Association Corporate Growth Logo
PRIME exits member masource-logo
CM&AP PRIME exits
bottom of page